- 現金殖利率: N/A、總殖利率: 4.76%、5年平均現金配發率: 23.06%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -2.11 | 0 | 0.00 | 0 | 0.50 | -47.92 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | 0.41 | 272.73 | 0.04 | 0.0 | 0.96 | 0.0 | 9.76 | -73.17 | 234.15 | -73.17 | 243.90 | -73.17 |
| 2021 (8) | 0.11 | -93.45 | 0.04 | 0 | 0.96 | -2.04 | 36.36 | 0 | 872.73 | 1396.1 | 909.09 | 1458.44 |
| 2020 (7) | 1.68 | 0 | 0.00 | 0 | 0.98 | 0 | 0.00 | 0 | 58.33 | 0 | 58.33 | 0 |
| 2019 (6) | -0.57 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | -1.62 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | 1.28 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | -0.63 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.67 | -148.15 | 24.72 | -0.10 | 37.5 | 9.09 | -1.34 | -91.43 | 31.63 |
| 24Q2 (19) | -0.27 | 37.21 | 69.32 | -0.16 | -60.0 | 30.43 | -0.70 | -62.79 | 34.58 |
| 24Q1 (18) | -0.43 | -186.67 | -104.76 | -0.10 | -25.0 | -11.11 | -0.43 | 79.62 | -104.76 |
| 23Q4 (17) | -0.15 | 83.15 | 83.33 | -0.08 | 27.27 | -166.67 | -2.11 | -7.65 | -614.63 |
| 23Q3 (16) | -0.89 | -1.14 | -207.23 | -0.11 | 52.17 | 52.17 | -1.96 | -83.18 | -249.62 |
| 23Q2 (15) | -0.88 | -319.05 | 20.0 | -0.23 | -155.56 | -360.0 | -1.07 | -409.52 | -322.92 |
| 23Q1 (14) | -0.21 | 76.67 | -112.07 | -0.09 | -200.0 | -50.0 | -0.21 | -151.22 | -112.07 |
| 22Q4 (13) | -0.90 | -208.43 | -208.43 | -0.03 | 86.96 | 96.1 | 0.41 | -68.7 | 272.73 |
| 22Q3 (12) | 0.83 | 175.45 | 1975.0 | -0.23 | -360.0 | -666.67 | 1.31 | 172.92 | 279.45 |
| 22Q2 (11) | -1.10 | -163.22 | 44.44 | -0.05 | 16.67 | 91.67 | 0.48 | -72.41 | 156.47 |
| 22Q1 (10) | 1.74 | 109.64 | 53.98 | -0.06 | 92.21 | 33.33 | 1.74 | 1481.82 | 53.98 |
| 21Q4 (9) | 0.83 | 1975.0 | 118.2 | -0.77 | -2466.67 | 40.31 | 0.11 | 115.07 | -93.45 |
| 21Q3 (8) | 0.04 | 102.02 | -97.16 | -0.03 | 95.0 | 40.0 | -0.73 | 14.12 | -111.72 |
| 21Q2 (7) | -1.98 | -275.22 | -137.22 | -0.60 | -566.67 | -160.87 | -0.85 | -175.22 | -117.63 |
| 21Q1 (6) | 1.13 | 124.78 | 351.11 | -0.09 | 93.02 | -80.0 | 1.13 | -32.74 | 351.11 |
| 20Q4 (5) | -4.56 | -423.4 | -1472.41 | -1.29 | -2480.0 | -12800.0 | 1.68 | -73.03 | 394.74 |
| 20Q3 (4) | 1.41 | -73.5 | 0.0 | -0.05 | 78.26 | 0.0 | 6.23 | 29.25 | 0.0 |
| 20Q2 (3) | 5.32 | 1282.22 | 0.0 | -0.23 | -360.0 | 0.0 | 4.82 | 1171.11 | 0.0 |
| 20Q1 (2) | -0.45 | -55.17 | 0.0 | -0.05 | -400.0 | 0.0 | -0.45 | 21.05 | 0.0 |
| 19Q4 (1) | -0.29 | 0.0 | 0.0 | -0.01 | 0.0 | 0.0 | -0.57 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 1.58 | -1.73 | 9.08 | 15.68 | 7.83 | 4.65 | N/A | - | ||
| 2024/10 | 1.61 | 10.41 | 6.67 | 14.09 | 7.69 | 4.51 | N/A | - | ||
| 2024/9 | 1.46 | 1.33 | 4.42 | 12.48 | 7.82 | 4.28 | 0.46 | - | ||
| 2024/8 | 1.44 | 4.02 | 5.96 | 11.02 | 8.29 | 4.08 | 0.48 | - | ||
| 2024/7 | 1.38 | 9.98 | 8.84 | 9.58 | 8.65 | 4.02 | 0.49 | - | ||
| 2024/6 | 1.26 | -8.54 | 10.09 | 8.2 | 8.62 | 4.07 | 0.47 | - | ||
| 2024/5 | 1.38 | -4.09 | 16.29 | 6.94 | 8.35 | 4.27 | 0.45 | - | ||
| 2024/4 | 1.44 | -1.3 | 6.94 | 5.56 | 6.55 | 4.15 | 0.46 | - | ||
| 2024/3 | 1.45 | 15.54 | 1.92 | 4.12 | 6.42 | 4.12 | 0.5 | - | ||
| 2024/2 | 1.26 | -10.83 | 19.28 | 2.67 | 9.04 | 4.05 | 0.51 | - | ||
| 2024/1 | 1.41 | 2.5 | 1.29 | 1.41 | 1.29 | 4.24 | 0.49 | - | ||
| 2023/12 | 1.38 | -5.13 | -3.13 | 15.91 | -7.57 | 4.34 | 0.46 | - | ||
| 2023/11 | 1.45 | -3.89 | -5.29 | 14.54 | -7.97 | 4.36 | 0.46 | - | ||
| 2023/10 | 1.51 | 8.08 | -2.22 | 13.09 | -8.26 | 4.27 | 0.47 | - | ||
| 2023/9 | 1.4 | 2.82 | 9.18 | 11.57 | -8.99 | 4.03 | 0.45 | - | ||
| 2023/8 | 1.36 | 6.85 | 5.67 | 10.18 | -11.03 | 3.78 | 0.48 | - | ||
| 2023/7 | 1.27 | 11.24 | -2.1 | 8.82 | -13.15 | 3.6 | 0.51 | - | ||
| 2023/6 | 1.14 | -3.39 | -15.3 | 7.55 | -14.77 | 3.67 | 0.53 | - | ||
| 2023/5 | 1.18 | -11.8 | -21.24 | 6.4 | -14.67 | 3.95 | 0.49 | - | ||
| 2023/4 | 1.34 | -5.93 | -32.2 | 5.22 | -13.02 | 3.82 | 0.5 | - | ||
| 2023/3 | 1.43 | 35.23 | 7.52 | 3.88 | -3.58 | 3.88 | 0.55 | - | ||
| 2023/2 | 1.06 | -24.28 | -3.79 | 2.45 | -9.05 | 3.87 | 0.55 | - | ||
| 2023/1 | 1.39 | -1.97 | -12.67 | 1.39 | -12.67 | 4.35 | 0.49 | - | ||
| 2022/12 | 1.42 | -7.25 | 1.54 | 17.22 | -3.37 | 4.5 | 0.49 | - | ||
| 2022/11 | 1.53 | -0.77 | -0.2 | 15.8 | -3.79 | 4.36 | 0.51 | - | ||
| 2022/10 | 1.54 | 20.69 | 3.43 | 14.26 | -4.16 | 4.11 | 0.54 | - | ||
| 2022/9 | 1.28 | -0.48 | -13.68 | 12.72 | -5.01 | 3.87 | 0.55 | - | ||
| 2022/8 | 1.29 | -1.02 | -15.86 | 11.44 | -3.93 | 3.94 | 0.54 | - | ||
| 2022/7 | 1.3 | -3.75 | -17.83 | 10.15 | -2.17 | 4.15 | 0.51 | - | ||
| 2022/6 | 1.35 | -10.16 | -25.15 | 8.85 | 0.68 | 4.83 | 0.4 | - | ||
| 2022/5 | 1.5 | -24.07 | -18.13 | 7.5 | 7.35 | 4.81 | 0.4 | - | ||
| 2022/4 | 1.98 | 49.17 | 61.42 | 6.0 | 16.43 | 4.4 | 0.44 | 中天生技與全家超商合作聯名品牌FamilyMart Collection保健品，在全家4,000家門市銷售，提供消費者便利購買的系列優質保健品。 | ||
| 2022/3 | 1.33 | 20.99 | -6.21 | 4.02 | 2.38 | 4.02 | 0.53 | - | ||
| 2022/2 | 1.1 | -31.27 | -7.75 | 2.69 | 7.22 | 4.09 | 0.52 | - | ||
| 2022/1 | 1.6 | 13.98 | 20.7 | 1.6 | 20.7 | 4.53 | 0.47 | - | ||
| 2021/12 | 1.4 | -8.85 | 4.38 | 17.82 | 11.29 | 4.43 | 0.49 | - | ||
| 2021/11 | 1.54 | 2.84 | 7.79 | 16.42 | 11.92 | 4.51 | 0.48 | - | ||
| 2021/10 | 1.49 | 0.72 | 15.81 | 14.88 | 12.35 | 4.51 | 0.48 | - | ||
| 2021/9 | 1.48 | -2.99 | 7.4 | 13.39 | 11.77 | 4.59 | 0.38 | - | ||
| 2021/8 | 1.53 | -3.34 | 12.89 | 11.91 | 12.34 | 4.91 | 0.36 | - | ||
| 2021/7 | 1.58 | -12.33 | 36.06 | 10.38 | 12.26 | 5.22 | 0.34 | - | ||
| 2021/6 | 1.8 | -1.73 | 51.44 | 8.79 | 8.79 | 4.87 | 0.37 | 因受疫情影響，國人對保健及有機食品需求增加，故本月營收較去年同期大幅成長。 | ||
| 2021/5 | 1.84 | 49.71 | 50.35 | 6.99 | 1.41 | 4.48 | 0.4 | 因受疫情影響，國人對保健及有機食品需求增加，故本月營收較去年同期大幅成長。 | ||
| 2021/4 | 1.23 | -13.33 | -18.44 | 5.15 | -9.12 | 3.83 | 0.47 | - | ||
| 2021/3 | 1.42 | 19.0 | -7.49 | 3.93 | -5.76 | 3.93 | 0.46 | - | ||
| 2021/2 | 1.19 | -10.06 | -10.56 | 2.51 | -4.75 | 3.85 | 0.47 | - | ||
| 2021/1 | 1.32 | -1.42 | 1.15 | 1.32 | 1.15 | 4.09 | 0.44 | - | ||
| 2020/12 | 1.34 | -5.87 | 10.28 | 16.01 | 9.2 | 4.06 | 0.45 | - | ||
| 2020/11 | 1.43 | 10.49 | -1.16 | 14.67 | 9.1 | 4.1 | 0.45 | - | ||
| 2020/10 | 1.29 | -6.58 | -8.33 | 13.25 | 10.35 | 4.02 | 0.45 | - | ||
| 2020/9 | 1.38 | 1.96 | 15.08 | 11.98 | 13.03 | 3.9 | 0.46 | - | ||
| 2020/8 | 1.35 | 16.48 | 5.64 | 10.6 | 12.77 | 3.71 | 0.49 | - | ||
| 2020/7 | 1.16 | -2.42 | 0.5 | 9.24 | 13.9 | 3.57 | 0.51 | - | ||
| 2020/6 | 1.19 | -2.44 | 7.15 | 8.08 | 16.13 | 3.92 | 0.44 | - | ||
| 2020/5 | 1.22 | -18.79 | 4.37 | 6.89 | 17.83 | 4.25 | 0.41 | - | ||
| 2020/4 | 1.5 | -1.7 | 24.71 | 5.67 | 21.2 | 4.36 | 0.4 | - | ||
| 2020/3 | 1.53 | 15.06 | 26.9 | 4.17 | 19.98 | 4.17 | 0.43 | - | ||
| 2020/2 | 1.33 | 1.71 | 32.2 | 2.64 | 16.29 | 3.85 | 0.46 | - | ||
| 2020/1 | 1.31 | 7.47 | 3.61 | 1.31 | 3.61 | 0.0 | N/A | - | ||
| 2019/12 | 1.22 | -15.65 | -1.55 | 14.66 | 1.25 | 0.0 | N/A | - |
